ZYDUS LIFESCIENCES
Back to Cashflow Statement
|
ZYDUS LIFESCIENCES Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹5,807 Cr | ₹1,995 Cr | ₹-1,779 Cr | ₹-4,400 Cr | ₹-868 Cr |
What is the latest Cash Flow from Financing Activities ratio of ZYDUS LIFESCIENCES ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2026 | ₹5,807 Cr |
| Mar2025 | ₹1,995 Cr |
| Mar2024 | ₹-1,779 Cr |
| Mar2023 | ₹-4,400 Cr |
| Mar2022 | ₹-868 Cr |
How is Cash Flow from Financing Activities of ZYDUS LIFESCIENCES Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2026 | ₹5,807 Cr | 191.03 | |
| Mar2025 | ₹1,995 Cr | Positive | |
| Mar2024 | ₹-1,779 Cr | Negative | |
| Mar2023 | ₹-4,400 Cr | Negative | |
| Mar2022 | ₹-868 Cr | - | |
Compare Cash Flow from Financing Activities of peers of ZYDUS LIFESCIENCES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ZYDUS LIFESCIENCES | ₹118,303.5 Cr | 5.2% | -2.2% | 16.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹422,991.0 Cr | 1.1% | -4.2% | 4.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹256,310.0 Cr | 7.5% | 1.3% | 45.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹173,604.0 Cr | 1.8% | -6.3% | 26.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹111,722.0 Cr | 9.3% | 9.5% | 4.3% | Stock Analytics | |
| CIPLA | ₹109,628.0 Cr | 1.5% | -2.3% | -17.3% | Stock Analytics | |
ZYDUS LIFESCIENCES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ZYDUS LIFESCIENCES | 5.2% |
-2.2% |
16.3% |
| SENSEX | 1.2% |
0.4% |
-12.2% |
You may also like the below Video Courses